Publicacions
-
Chantada L, Gorostegui M, Lowe J, Ranasinghe N, Villegas L, Geel J, Howard S, Bouffet E, Chantada G, Challinor J and Cappellano A.
SIOP pediatric oncology services Global Mapping Program: Latin American data collection
PEDIATRIC BLOOD & CANCER . 71(2): . Nº de cites: 2
-
van Tilburg CM, Kilburn LB, Perreault S, Schmidt R, Azizi AA, Cruz-Martínez O, Zápotocký M, Scheinemann K, Meeteren AYNS, Sehested A, Opocher E, Driever PH, Avula S, Ziegler DS, Capper D, Koch A, Sahm F, Qiu J, Tsao LP, Blackman SC, Manley P, Milde T, Witt R, Jones DTW, Hargrave D and Witt O.
LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration
BMC Cancer . 24(1): 147-147. Nº de cites: 12
-
Brown, Elizabeth J., Balaguer-Lluna, Leire, Cribbs, Adam P., Philpott, Martin, Campo, Leticia, Browne, Molly, Wong, Jong Fu, Oppermann, Udo, Carcaboso AM, Bullock, Alex N. and Farnie, Gillian.
PRMT5 inhibition shows in vitro efficacy against H3K27M-altered diffuse midline glioma, but does not extend survival in vivo
SCIENTIFIC REPORTS . 14(1): . Nº de cites: 1
-
Cancela MB, Dinardi M, Aschero MR, Zugbi S, Chantada G, Baroni L and Schaiquevich P.
The importance of basic and translational research in caring for children with malignant solid tumors in Latin America
REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH . 48: .
-
Wiese M, Pohlmeier B, Kubiak K, El-Khouly FE, Sitte M, Carcaboso AM, Baugh JN, Perwein T, Nussbaumer G, Karremann M, Gielen GH, Salinas G and Kramm CM.
Boswellic acid formulations are not suitable for treatment of pediatric high-grade glioma due to tumor promoting potential
Journal of Traditional and Complementary Medicine . 14(1): 101-108.
-
Aschero MR, Ganiewich D, Lamas G, Restrepo-Perdomo CA, Ottaviani D, Zugbi S, Camarero S, Néspoli E, Cuadrado-Vilanova M, Pérez-Jaume S, Pascual-Pastó G, Sampor C, Grigorovski N, Salas B, Suñol M, Carcaboso AM, Mora J, de Dávila MTG, Doz F, Radvanyi F, Abramson DH, Llera AS, Schaiquevich PS, Lubieniecki F and Chantada G.
Immunohistochemical expression of TFF1 is a marker of poor prognosis in retinoblastoma
PEDIATRIC BLOOD & CANCER . 71(1): . Nº de cites: 1
-
Simao-Rafael M, Cruz-Martínez O, Pérez-Jaume S, Santa-María López V, Lavarino C, Salvador-Hernandez H, Muchart-Lopez J, Hinojosa J, Suñol M and Morales-La Madrid A.
Use of bevacizumab in pediatric low-grade glioma: Ten-year experience in a single center
EJC Paediatric Oncology . 2: 100115.
-
Zugbi S, Aschero R, Ganiewich D, Cancela MB, Winter U, Ottaviani D, Sampor C, Dinardi M, Torbidoni AV, Mena M, Balaguer-Lluna L, Lamas G, Sgroi M, Lagomarsino E, Lubieniecki F, Fandiño A, Radvanyi F, Abramson DH, Podhajcer O, Llera AS, Cafferata EG, Chantada G, Carcaboso AM and Schaiquevich P.
Establishment and Comprehensive Characterization of a Novel Preclinical Platform of Metastatic Retinoblastoma for Therapeutic Developments
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE . 64(15): 27-27. Nº de cites: 2
-
Chirlaque MD, Peris-Bonet R, Sánchez A, Cruz-Martínez O, Marcos-Gragera R, Gutiérrez-Ávila G, Quirós-García JR, Almela-Vich F, López de Munain A, Sánchez MJ, Franch-Sureda P, Ardanaz E, Galceran J, Martos C, Salmerón D, Gatta G, Botta L, Cañete A and The Spanish Childhood Cancer Epidemiology Working Group.
Childhood and Adolescent Central Nervous System Tumours in Spain: Incidence and Survival over 20 Years: A Historical Baseline for Current Assessment
Cancers . 15(24): .
-
Berry JL, Pike S, Rajagopalan A, Reid MW, Fabian ID, Afshar AR, Alejos A, Alemany-Rubio E, Carreras YA, Arazi M, Astbury NJ, Bascaran C, Binkley E, Blum S, Boldt HC, Bonanomi MTBC, Bowman R, Brennan RC, Burton MJ, Calderón-Sotelo P, Jara DAC, Cano MR, Castillo L, Cavieres I, Cerna DQ, Chandramohan A, Chantada G, Corson TW, Cowan-Lyn KE, Davanzo JM, Demirci H, Coronado RYD, Dimaras H, Macedo CRD, Ericksen C, Fandiño AC, Fernández DDPG, Foster A, Fu LD, Fuentes-Alabi SL, Garcia JL, Pacheco HNG, Girón AV, Goenz MA, Gold AS, Gomel N, Gonzalez E, Perez GG, González-Rodríguez L, Graells J, Grigorovski NDAK, Hamel P, Hansen ED, Harbour JW, Elizabeth Hartnett M, Hassan M, Hubbard GB, Kapelushnik N, Kim JW, Larson SA, Laurenti KD, Leverant AA, Li C, López JP, Luna-Fineman S, Magrath GN, Mallipatna A, Mattosinho CCDS, Mets MB, Miller A, Mruthyunjaya P, Murray TG, Oliver SCN, Oporto J, Ortega-Hernández M, Ossandon D, Morales CRP, Paton KE, Plager DA, Polania RA, Ponce J, Quintero D K, Ramasubramanian A, Ramirez-Ortiz MA, Randhawa JK, Romero L, Salas B, Sánchez GL, Orozco AJS, Sgroi M, Shah AS, Shields CL, Singh AD, Skalet AH, Stacey AW, Stahl ED, Strahlendorf C, Suarez MEC, Superstein R, Leiva FFT, Teixeira LF, Uner OE, Anchaya JKV, Vaughan LO, Villegas VM, Wilson MW, Yaghy A, Yee RI, López AM and Zondervan M.
Retinoblastoma Outcomes in the Americas: a prospective analysis of 491 children with retinoblastoma from 23 American countries.
AMERICAN JOURNAL OF OPHTHALMOLOGY . : . Nº de cites: 1